CAS 158966-92-8: Montelukast

Formule : C₃₅H₃₆ClNO₃S

InChI : InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1

Code InChI : InChIKey=UCHDWCPVSPXUMX-TZIWLTJVSA-N

SMILES : O=C(O)CC1(CSC(C=2C=CC=C(C=CC=3N=C4C=C(Cl)C=CC4=CC3)C2)CCC=5C=CC=CC5C(O)(C)C)CC1

Synonymes :

• (1-{[(1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl)sulfanyl]methyl}cyclopropyl)acetic acid
• (2Beta,3Alpha,5Alpha,16Beta,17Beta)-3,17-Bis(Acetyloxy)-16-(1-Methylpiperidinium-1-Yl)-2-(Piperidin-1-Yl)Androstane Bromide
• (R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
• 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid
• 1-[[[(R)-1-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid
• 2-[1-[[(1R)-1-[3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
• 2-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropyl]acetic acid
• Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-
• Cyclopropaneacetic acid, 1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, [R-(E)]-
• Montelukas
• Velukast
• [1-[[[(1R)-1-[3-[(E)-2-(7-Chloroquinolin-2-yl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetic acid
• {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
• {1-[({(1R)-1-{3-[2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid

Montelukast Sodium

CAS : 151767-02-1 158966-92-8

• Formule : C₃₅H₃₅ClNNaO₃S
• Degré de pureté : >98.0%(T)(HPLC)
• Couleur et forme : White to Almost white powder to crystal
• Masse moléculaire : 608.17

Cyclopropaneacetic acid,1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-

CAS : 158966-92-8

• Formule : C₃₅H₃₆ClNO₃S
• Degré de pureté : 99%
• Couleur et forme : Solid
• Masse moléculaire : 586.1832400000001

Montelukast Impurity 32

CAS : 1093746-29-2 158966-92-8

• Formule : C₂₉H₂₆ClNO
• Masse moléculaire : 439.98

Montelukast

CAS : 158966-92-8

Montelukast (Singular), oral asthma med, linked to rare liver injury.

• Formule : C₃₅H₃₆ClNO₃S
• Degré de pureté : 100% - 99.74%
• Couleur et forme : Solid
• Masse moléculaire : 586.18

Montelukast

CAS : 158966-92-8

Leukotriene receptor antagonist

• Formule : C₃₅H₃₆ClNO₃S
• Degré de pureté : Min. 98 Area-%
• Couleur et forme : White Powder
• Masse moléculaire : 586.18 g/mol

Montelukast - Bio-X ™

CAS : 158966-92-8

Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and …

• Formule : C₃₅H₃₆ClNO₃S
• Degré de pureté : Min. 98 Area-%
• Couleur et forme : Powder
• Masse moléculaire : 586.19 g/mol

Montelukast-d6 Sodium Salt

CAS : 1093746-29-2 151767-02-1 158966-92-8

• Formule : C₃₅H₂₉D₆ClNNaO₃S
• Couleur et forme : Neat
• Masse moléculaire : 614.2

2’-Des(1-hydroxy-1-methylethyl)-2’-carboxy Montelukast Bissodium Salt

CAS : 158966-92-8

Applications 2’-Des(1-hydroxy-1-methylethyl)-2’-carboxy Montelukast Bissodium Salt is an impurity of Montelukast Sodium Salt (M568000), a selective …

• Formule : C₃₃H₂₈ClNNa₂O₄S
• Couleur et forme : Neat
• Masse moléculaire : 616.077